Fatty Acid Synthase
Fatty Acid Synthase (FAS) is a multi-enzyme complex responsible for the synthesis of long-chain fatty acids. Overexpression of FAS is associated with various metabolic disorders, including obesity, diabetes, and cancer. Inhibiting FAS can reduce lipid biosynthesis and induce apoptosis in cancer cells, making it a promising target for cancer therapy and metabolic disease research. At CymitQuimica, we provide a variety of FAS inhibitors to support your research in oncology, metabolism, and therapeutic development.
Found 40 products for "Fatty Acid Synthase".
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Fatostatin hydrobromide
CAS:Fatostatin hydrobromide (Fatostatin A HBr), an inhibitor of sterol regulatory element binding protein (SREBP), impairs the activation of SREBP-1 and SREBP-2.Formula:C18H19BrN2SPurity:98.62% - 99.91%Color and Shape:SolidMolecular weight:375.326Ref: TM-T6832
5mg48.00€1mL*10mM (DMSO)50.00€10mg70.00€25mg112.00€50mg182.00€100mg309.00€200mg447.00€500mg747.00€TVB-3664
CAS:TVB-3664 is an orally active, selective, highly bioavailable fatty acid synthase inhibitor (FASN).Cost-effective and quality-assured.Formula:C25H23F3N4O2Purity:99.17% - 99.64%Color and Shape:SolidMolecular weight:468.47Ref: TM-T17181
1mg114.00€5mg268.00€1mL*10mM (DMSO)268.00€10mg432.00€25mg708.00€50mg1,044.00€100mg1,423.00€Fas C-Terminal Tripeptide Acetate
Fas C-Terminal Tripeptide Acetate shows inhibitory activity of Fas/FAP-1 binding.Formula:C18H33N3O8Purity:97.85%Color and Shape:White SolidMolecular weight:419.47FGH10019
CAS:FGH10019 is a novel inhibitor of sterol regulatory element-binding protein (SREBP) ( IC50 :1 μM).Formula:C18H19N3O2S2Purity:98.93%Color and Shape:SolidMolecular weight:373.49Ref: TM-T7798
1mg70.00€5mg152.00€1mL*10mM (DMSO)156.00€10mg212.00€25mg355.00€50mg505.00€100mg685.00€200mg888.00€Ac-CoA Synthase Inhibitor1
CAS:Ac-CoA Synthase Inhibitor1 (ACSS2 inhibitor) is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2).Formula:C20H18N4O2S2Purity:99.26% - 99.84%Color and Shape:SolidMolecular weight:410.51Fatostatin
CAS:Fatostatin inhibits SREBP-1/2 by binding to SCAP, blocking their ER-Golgi transport.Formula:C18H18N2SPurity:99.77% - 99.92%Color and Shape:White SolidMolecular weight:294.414Ref: TM-T9266
2mg34.00€5mg48.00€1mL*10mM (DMSO)50.00€10mg70.00€25mg112.00€50mg182.00€100mg309.00€200mg465.00€Betulin ditosylate
CAS:Betulinditosylate is a derivative of Betulin, which functions as an SREBP inhibitor.Formula:C44H62O6S2Color and Shape:SolidMolecular weight:751.09HS80
CAS:HS-80, a Fasnall enantiomer, selectively inhibits FASN, blocking lipid synthesis (IC50: 7.13 μM).Formula:C19H22N4SPurity:98%Color and Shape:SolidMolecular weight:338.47HS79
CAS:HS-79, a Fasnall enantiomer, selectively inhibits FASN with an IC50 of 1.57 μM, blocking tritiated acetate lipid incorporation.Formula:C19H22N4SPurity:98%Color and Shape:SolidMolecular weight:338.47FASN-IN-4
CAS:FAS-IN-1 is a potent inhibitor of Fatty acid synthase (FAS) wtih IC50 of 10 nM.Formula:C26H27N3O4SPurity:98%Color and Shape:SolidMolecular weight:477.58FASN-IN-5
CAS:FASN-IN-5 is a FASN inhibitor, useful for studying cancer and metabolic diseases.Formula:C29H26N4O2Purity:99.88%Color and Shape:SolidMolecular weight:462.54Malic enzyme inhibitor ME1
CAS:Malic enzyme inhibitor ME1 (ME1) is a specific inhibitor of Malic enzyme (IC50 = 0.15 μM). Malic enzyme inhibitor ME1 reduces cell viability/metabolic activity.Formula:C20H21N3O3Purity:99.91%Color and Shape:SolidMolecular weight:351.4Ref: TM-T11940
1mg70.00€1mL*10mM (DMSO)148.00€5mg178.00€10mg326.00€25mg555.00€50mg790.00€100mg1,063.00€500mg2,152.00€CTL-06
CTL-06, a Fatty Acid Synthase (FASN) inhibitor with an IC50 of 3 μM, induces apoptosis, while CTL-12 impedes cell cycle progression in the Sub-G1/S phase andFormula:C21H21ClN4O4Color and Shape:SolidMolecular weight:428.87SREBP/SCAP-IN-2
CAS:SREBP/SCAP-IN-2 (compound 13) acts as a selective inhibitor of SREBP/SCAP [1].Formula:C27H37ClF2N4OColor and Shape:SolidMolecular weight:507.06FASN-IN-1
CAS:FASN-in-1 is an effective, specific inhibitor of fatty acid synthase (FASN), a compound specifically designed to target and inhibit the activity of the enzymeFormula:C18H25N3O3S2Purity:99.92% - >99.99%Color and Shape:White SolidMolecular weight:395.541,3-Dipalmitoyl-2-Docosahexaenoyl Glycerol
CAS:1,3-Dipalmitoyl-2-docosahexaenoyl glycerol, a triacylglycerol, features palmitic acid at the sn-1 and sn-3 positions and docosahexaenoic acid at the sn-2 position. Its dietary administration (30 g/kg) has been shown to decrease hepatic triglyceride and cholesterol levels in mice.Formula:C57H98O6Color and Shape:SolidMolecular weight:879.38FAS-IN-1 Tosylate
FAS-IN-1 Tosylate is an effective fatty acid synthase inhibitor;Has an IC50 of 10 nM.Formula:C33H35N3O7S2Purity:98%Color and Shape:SolidMolecular weight:649.78SREBP/SCAP-IN-1
CAS:SREBP/SCAP-IN-1 (compound 10b) serves as a selective inhibitor of SREBP/SCAP [1].Formula:C28H40F2N4OColor and Shape:SolidMolecular weight:486.64ONL-1204
CAS:ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment.Formula:C71H100N18O16Color and Shape:SolidMolecular weight:1461.66PFM046
CAS:PFM046 is an antagonist of the liver X receptor (LXR), effectively inhibiting the activation of LXRα and LXRβ, with IC50 values of 2.04 μM and 1.58 μM respectively. It reduces the expression of SCD1 and FASN while increasing ABCA1 expression, and demonstrates antitumor activity in mouse models.Formula:C29H42O2Color and Shape:SolidMolecular weight:422.643
